Biomedical Science and Research Journals | Phage Therapy to Prevent Nosocomial Bacterial Pneumonia in Patients with Severe COVID-19 in 2020

 

Phage Therapy to Prevent Nosocomial Bacterial Pneumonia in Patients with Severe COVID-19 in 2020

Abstract

The COVID-19 was reported to be a pandemic, according to the World Health Organization (WHO). Secondary bacterial pneumonia exacerbates respiratory problems and increases mortality in patients with COVID-19. Recently, 50% of the causes of death in these patients have been reported as nosocomial pneumonia in these cases. These bacteria have become multidrug-resistant. Phage production is a cost-benefit. Inhalation of phage cocktail with mesh nebulizer can be suitable to prevent secondary bacterial pulmonary infection in patients with severe COVID-19. To prevent secondary bacterial pneumonia and reduce mortality in patients with severe type COVID-19 and patients who are under a ventilator for a long time, the use of phage cocktail product by inhalation with mesh nebulizer device is recommended

Keywords: Pneumonia; COVID-19; Prevention; Phage therapy

Dear Editor

The COVID-19 was reported to be a pandemic, according to the World Health Organization (WHO). The SARS-COV2 is transmitted to humans through the respiratory system. The virus stimulates the immune system to secrete inflammatory substances and cytokine storm. This event can induce multi-organ damage. Secondary bacterial pneumonia exacerbates respiratory problems and increases mortality in patients with COVID-19. Recently, 50% of the causes of death in these patients have been reported as nosocomial pneumonia in these cases. The most common etiology of secondary bacterial pneumonia is Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumonia, and Acinetobacter baumannii. These bacteria have become multidrug-resistant due to improper rational usage of antibiotics, genetic mutation, and enzyme production. Phage therapy can be used to reduce the rate of these infections [1].

Phage production is a cost-benefit. Bacteriophages have recently been reported as an appropriate prevention and treatment option at the In-vitro, In-vivo, and several clinical trials. For optimal use of bacteriophages for these cases, the use of a phage cocktail that includes different phages is recommended. Phage cocktail not only increases the host range of phages but also reduces the likelihood of phage resistance [2].

Inhalation of phage cocktail with mesh nebulizer can be suitable to prevent secondary bacterial pulmonary infection in patients with severe COVID-19 and patients who are under a ventilator for a long time. The mesh nebulizer device produces the least changes in the structure of bacteriophages by producing aerosols with dimensions of less than 4 micrometers. It also minimizes decrease bacteriophage titers and active phages [3].

An inhaled phage cocktail with mesh nebulizer device can prevent secondary pulmonary bacterial infection in patients with COVID-19. To prevent secondary bacterial pneumonia and reduce mortality in patients with severe type COVID-19 and patients who are under a ventilator for a long time, the use of phage cocktail product by inhalation with mesh nebulizer device is recommended.

Disclosure

The authors report no conflicts of interest in this communication.

Funding information

The authors received no specific grant from any funding agency.

Ethics approval

Not applicable.

Acknowledgments

None.

Conflicts of Interest

No Conflict of interest.

For More information: https://biomedgrid.com/fulltext/volume10/phage-therapy-to-prevent-nosocomial-bacterial-pneumo%C2%ACnia-in-patients-with-severe-covid-19-in-2020.001563.php

Know More Information: Biomed Grid Please Click on : https://biomedgrid.com

For More information: Open Access Journals of Biomedical Science and Research: Journal of Biomedical Science 

Know More Information: Biomed Grid Please Click on : https://biomedgrid.com

Comments

Post a Comment

Popular posts from this blog

Biomedical Science and Research Journals | Advanced Applications of Biomaterials Based on Alginic Acid

Advanced Applications of Biomaterials Based on Alginic Acid Abstract Alginic acid, also known as algin or alginate, is a natural carbohydrate, which is derived from marine brown algae, as well as some microorganisms. It can be used in various applications. In particular, alginate has shown great potential in the areas of wound healing, drug delivery, in vitro cell culture, and tissue engineering, allowing the categorization of it as a promising biomaterial, or a basic component of other biomaterials. The unique characteristics of alginic acid, such as the biocompatibility, the mild required gelation conditions, the low toxicity, the relative low cost and the simple modifications, allow the development of alginate hydrogels, and alginate derivatives with enhanced properties. The aim of this review, is to present an overview of the properties of alginate, shedding light on the current and potential applications and suggesting new perspectives for future studies. Introduction Innovative b
Read more

Biomedical Science and Research Journals | Covid-19 Pandemic: Cardiovascular and Neurologic Impact, Early Signs and Symptoms

Image
  Covid-19 Pandemic: Cardiovascular and Neurologic Impact, Early Signs and Symptoms Abstract Background:  Scientists and physicians continue their cutting-edge work on bacteria, parasites and viruses, responsible for 17 million deaths each year worldwide. The purpose of this article is to review our clinical experience with COVID-19 patients observed in the Cardiovascular Division of Pompidou Hospital (University of Paris, France) and the Department of Neurology of the Eastern Piedmont University (Novara, Italy), related with the impact on the cardiovascular, hematologic, neurologic systems and sense organs. Mathematical modeling for pandemic spreading control (protection versus hazards), proposed by Vienna University of Technology (Austria), are analyzed. Methods:  We sought to characterize the cardiovascular and neurologic manifestations, in patients with Covid‐19. Special attention was given to initial signs and symptoms in order to facilitate early diagnosis and therapy. Indication
Read more

Biomedical Science and Research Journals | Phosphatidylethanol (PEth); the Superior Direct Alcohol Biomarker against Mean Corpuscular Volume (MCV), Aspartate Amino Transferase (AST), Alanine Aminotransferase (ALT), Gamma-Glutamyl Transferase (GGT) and Carbohydrate-Deficient Transferrin (CDT)

Image
Phosphatidylethanol (PEth); the Superior Direct Alcohol Biomarker against Mean Corpuscular Volume (MCV), Aspartate Amino Transferase (AST), Alanine Aminotransferase (ALT), Gamma-Glutamyl Transferase (GGT) and Carbohydrate-Deficient Transferrin (CDT) Editorial As ethanol itself is metabolised and excreted quickly from the body, assessing alcohol consumption with a blood test relies on other markers indicative of consumption. Traditional tests include Liver Function Testing (LFT), Carbohydrate Deficient Transferrin (CDT) Testing, and a Full Blood Count (FBC). Phosphatidylethanol (PEth) testing, on the other hand, is a direct biomarker of alcohol consumption, can only be detected when alcohol has been consumed, and is directly correlated with the level of alcohol consumed There are some difficulties when testing alcohol in blood to determine if alcohol had been abused. Due to these challenges in testing alcohol consumption behaviours across society, in the most recent decade
Read more